A share price of Koninklijke Philips N.V. ADR [PHG] is currently trading at $26.84, up 0.41%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PHG shares have gain 7.15% over the last week, with a monthly amount drifted -1.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Koninklijke Philips N.V. ADR [NYSE: PHG] stock has seen the most recent analyst activity on February 25, 2025, when Exane BNP Paribas upgraded its rating to a Outperform. Previously, UBS upgraded its rating to Buy on February 20, 2025. On October 29, 2024, upgrade upgraded it’s rating to Hold. Bernstein upgraded its rating to a Outperform. Exane BNP Paribas upgraded its rating to a Neutral. UBS upgraded its rating to Neutral for this stock on April 30, 2024. In a note dated April 30, 2024, JP Morgan upgraded an Neutral rating on this stock.
Koninklijke Philips N.V. ADR experienced fluctuations in its stock price throughout the past year between $19.10 and $32.91. Koninklijke Philips N.V. ADR [NYSE: PHG] shares were valued at $26.84 at the most recent close of the market.
Analyzing the PHG fundamentals
Trailing Twelve Months sales for Koninklijke Philips N.V. ADR [NYSE:PHG] were 19.49B which represents -15.22% decline. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.02%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.71 points at the first support level, and at 26.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.00, and for the 2nd resistance point, it is at 27.15.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Koninklijke Philips N.V. ADR [NYSE:PHG] is 1.23. In addition, the Quick Ratio stands at 0.84. Considering the valuation of this stock, the price to sales ratio is 1.27, the price to book ratio is 1.96.
